Recent advances in dermatology.
Novel therapies for dermatologic diseases are now widely available to the clinician. The topical immune modulators tacrolimus and pimecrolimus are likely to change the way in which inflammatory dermatoses are treated. Antiviral and antitumor effects of imiquimod, another immune-response modifier, are being studied to determine the ways in which it may affect the treatment of cutaneous viral infections and skin cancers. New topical treatments for onychomycosis and the current lack of effective treatments for nondermatophyte onychomycosis indicate the need for more effective treatment for this common disease. Exciting developments in skin substitutes and growth factors for acute and chronic wound care hold much promise for the future.
Wu
Sandra Jones
SJ
Division of Dermatology, Ohio State University, Columbus, Ohio, USA. wu-2@medctr.osu.edu
Tanphaichitr
Artthapol
A
Ly
Micki
M
D003880:Dermatology / Q000592:standards / Q000639:trends*; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D012871:Skin Diseases / Q000175:diagnosis* / Q000628:therapy*; D014481:United States